Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Leqembi’s EU Approval Process Delayed Over Advisory Group COI Considerations
The decision is not related to the product.
Mar 25 2024
•
By
Lisa Takagi
The court ruling led EMA to void the SAG-N decision for Leqembi due to potential COI concerns • Source: Shutterstock
More from Europe
More from Geography